Delivery Order SPE2DB22D1202-SPE2DB24FVJY7

Award Date 8/6/24
Potential Completion Date 8/27/24
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of KINERET 100 MG/0.67 ML SYRINGE 0.67ML. The $3,228.64 firm-fixed-price delivery order has an ultimate completion date of September 3, 2024. Amerisourcebergen, through its corporate office division, is providing this medication to support military treatment facilities and other federal healthcare programs. The award is not associated...
This federal contract award is for the delivery of Kineret 100 mg/0.67 ml syringes to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $3,228.64 firm fixed price delivery order was awarded on June 5, 2024 and has a completion date of June 27, 2024. The contract is not set aside and is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
This federal contract award, valued at $20,876.25, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of KINERET 100 MG/0.67 ML SYRINGE 0.67ML, with a completion date of December 18, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,228.64 firm-fixed-price delivery order is for the supply of 4565405936 KINERET 100 MG/0.67 ML SYRINGE 0.67ML. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal...
This federal contract award, valued at $1,614.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, for the delivery of 4,564,159,150 units of the specialty pharmaceutical drug Kineret 100 mg/0.67 ml syringe. The contract has a firm fixed price and is a delivery order with an ultimate completion date of April 24, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken,...
This is a $8,071.60 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA), a defense agency. The order is for the pharmaceutical product "KINERET 100 MG/0.67 ML SYRINGE 0.67ML" with a completion date of May 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award, valued at $3,228.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Kineret 100 mg/0.67 mL syringes. The contract is a delivery order with a firm fixed price, and the ultimate completion date is September 5, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts to supply a wide range of pharmaceutical products and medical...
This federal contract award is for the delivery of Kineret 100 mg/0.67 mL syringes to the Defense Logistics Agency (DLA) Troop Support Medical, a major medical supply chain organization within the Department of Defense. The contract was awarded to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor, on July 29, 2024 with a ceiling value of $6,457.28 and a completion date of August 19, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This federal contract award, valued at $3,228.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of 4564977649 - KINERET 100 MG/0.67 ML SYRINGE 0.67ML, with a period of performance through July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly with the Department of Defense (DoD)...
This federal contract award, valued at $1,614.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of KINERET 100MG/.67ML 7S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVJY7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,457.28 firm-fixed-price delivery order is for the supply of 0.67 mL KINERET 100 mg syringes. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract without any set-aside designation. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, to provide a wide range of critical pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other government healthcare programs.

Generated 11/5/24, 9:07 AM